Question 1

What specific treatments will I receive if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the chemotherapy and radiation involved?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my condition changes during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or travel requirements I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HD16 for Early Stage Hodgkin Lymphoma clinical trial (NCT00736320). Contact the study team or your healthcare provider for specific answers.

What this study is about